First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

The characterization of the adaptive immune response to COVID-19 vaccination in individuals who recovered from SARS-CoV-2 infection may define current and future clinical practice. To determine the effect of the 2-dose BNT162b2 mRNA COVID-19 vaccination schedule in individuals who recovered from COV...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Invest
Main Authors: Mazzoni, Alessio, Di Lauria, Nicoletta, Maggi, Laura, Salvati, Lorenzo, Vanni, Anna, Capone, Manuela, Lamacchia, Giulia, Mantengoli, Elisabetta, Spinicci, Michele, Zammarchi, Lorenzo, Kiros, Seble Tekle, Rocca, Arianna, Lagi, Filippo, Colao, Maria Grazia, Parronchi, Paola, Scaletti, Cristina, Turco, Lucia, Liotta, Francesco, Rossolini, Gian Maria, Cosmi, Lorenzo, Bartoloni, Alessandro, Annunziato, Francesco
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Clinical Investigation 2021
Assuntos:
Concise Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8203460/
https://ncbi.nlm.nih.gov/pubmed/33939647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI149150
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares